Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding and evaluating clinical trials

M Bigby1, A S Gadenne

  • 1Department of Dermatology and Cutaneous Biology Research Center, Harvard Medical School, Boston, USA.

Journal of the American Academy of Dermatology
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The sentinel node biopsy has not come of age.

The British journal of dermatology·2019
Same author

Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.

The British journal of dermatology·2018
Same author

Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?'

The British journal of dermatology·2017
Same author

Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis.

The British journal of dermatology·2016
Same author

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.

The British journal of dermatology·2015
Same author

WebDoctor: Your Online Guide to Health Care and Wellness.

Archives of dermatology·2014
Same journal

Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026
Same journal

Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
See all related articles

This review guides clinicians in evaluating clinical trials, emphasizing randomized controlled trials for reliable treatment efficacy and safety data. It offers a method to efficiently assess trial quality and identify robust evidence.

Area of Science:

  • Clinical Research Methodology
  • Evidence-Based Medicine

Background:

  • Randomized clinical trials (RCTs) are the gold standard for determining optimal medical treatments.
  • Many commonly used data sources lack sufficient detail or contain biases, hindering reliable treatment evaluation.
  • Efficiently assessing the quality of clinical trials is crucial for healthcare professionals.

Purpose of the Study:

  • To provide essential knowledge for understanding and evaluating clinical trials.
  • To enable clinicians to efficiently identify high-quality trials and reliable treatment information.
  • To outline a systematic method for assessing the validity and applicability of clinical trial findings.

Main Methods:

  • Focus on recognizing and evaluating key features that strengthen clinical trials.

Related Experiment Videos

  • Emphasis on patient selection, allocation, and the use of appropriate control groups.
  • Inclusion of randomization, blinding, outcome variable selection, and analysis of patient compliance and dropouts.

    • Main Results:

    • A structured approach to clinical trial evaluation allows for efficient identification of reliable treatment data.
    • Key trial design elements, such as randomization and blinding, are critical for minimizing bias.
    • Proper statistical analysis and reporting of results are essential for validating conclusions.

    Conclusions:

    • Rigorous evaluation of clinical trials ensures the selection of the most effective and safe treatments.
    • The proposed method aids clinicians in prioritizing and interpreting high-quality research.
    • Understanding trial methodology is fundamental to advancing evidence-based healthcare practices.